Species | Target name | Source | Bibliographic reference |
---|---|---|---|
Homo sapiens | RAB9A, member RAS oncogene family | Starlite/ChEMBL | No references |
Homo sapiens | glucagon-like peptide 1 receptor | Starlite/ChEMBL | No references |
Homo sapiens | bromodomain adjacent to zinc finger domain, 2B | Starlite/ChEMBL | No references |
Species | Potential target | Known druggable target | Length | Alignment span | Identity |
---|---|---|---|---|---|
Plasmodium falciparum | ras-related protein Rab-5B | RAB9A, member RAS oncogene family | 201 aa | 165 aa | 30.9 % |
Loa Loa (eye worm) | pigment dispersing factor receptor c | glucagon-like peptide 1 receptor | 463 aa | 388 aa | 25.8 % |
Species | Potential target | Raw | Global | Species |
---|---|---|---|---|
Brugia malayi | latrophilin 2 splice variant baaae | 0.0068 | 0.3876 | 0.326 |
Loa Loa (eye worm) | hypothetical protein | 0.0031 | 0.1013 | 0.086 |
Echinococcus granulosus | tar DNA binding protein | 0.0126 | 0.8468 | 0.8442 |
Brugia malayi | Bromodomain containing protein | 0.0046 | 0.2186 | 0.1401 |
Echinococcus multilocularis | muscleblind protein | 0.0146 | 1 | 1 |
Schistosoma mansoni | tar DNA-binding protein | 0.0126 | 0.8468 | 1 |
Brugia malayi | Bromodomain containing protein | 0.0091 | 0.5675 | 0.524 |
Brugia malayi | Calcitonin receptor-like protein seb-1 | 0.0099 | 0.6343 | 0.5975 |
Brugia malayi | Latrophilin receptor protein 2 | 0.0031 | 0.1013 | 0.0109 |
Echinococcus granulosus | zinc finger protein | 0.0024 | 0.0407 | 0.0244 |
Schistosoma mansoni | methyl-cpg binding protein mbd | 0.0021 | 0.0167 | 0.0197 |
Echinococcus granulosus | bromodomain adjacent to zinc finger domain | 0.0072 | 0.422 | 0.4122 |
Echinococcus granulosus | GPCR family 2 | 0.0031 | 0.1013 | 0.086 |
Loa Loa (eye worm) | hypothetical protein | 0.0099 | 0.6343 | 0.6281 |
Echinococcus multilocularis | diuretic hormone 44 receptor GPRdih2 | 0.0031 | 0.1013 | 0.086 |
Loa Loa (eye worm) | RNA recognition domain-containing protein domain-containing protein | 0.0126 | 0.8468 | 0.8442 |
Brugia malayi | RNA recognition motif domain containing protein | 0.0126 | 0.8468 | 0.8314 |
Schistosoma mansoni | zinc finger protein | 0.0024 | 0.0407 | 0.048 |
Echinococcus granulosus | bromodomain adjacent to zinc finger domain | 0.0043 | 0.1961 | 0.1825 |
Echinococcus multilocularis | fetal alzheimer antigen, falz | 0.0027 | 0.0689 | 0.0531 |
Leishmania major | hypothetical protein, conserved | 0.0018 | 0 | 0.5 |
Trypanosoma cruzi | ISWI complex protein | 0.0018 | 0 | 0.5 |
Loa Loa (eye worm) | hypothetical protein | 0.0146 | 1 | 1 |
Schistosoma mansoni | tar DNA-binding protein | 0.0126 | 0.8468 | 1 |
Trypanosoma cruzi | ISWI complex protein | 0.0018 | 0 | 0.5 |
Loa Loa (eye worm) | pigment dispersing factor receptor c | 0.0099 | 0.6343 | 0.6281 |
Echinococcus granulosus | fetal alzheimer antigen falz | 0.0027 | 0.0689 | 0.0531 |
Brugia malayi | Corticotropin releasing factor receptor 2 precursor, putative | 0.0099 | 0.6343 | 0.5975 |
Brugia malayi | TAR-binding protein | 0.0126 | 0.8468 | 0.8314 |
Loa Loa (eye worm) | transcription factor SMAD2 | 0.012 | 0.7988 | 0.7954 |
Schistosoma mansoni | tar DNA-binding protein | 0.0126 | 0.8468 | 1 |
Schistosoma mansoni | bromodomain containing protein | 0.0076 | 0.4561 | 0.5385 |
Loa Loa (eye worm) | PHD-finger family protein | 0.0025 | 0.0507 | 0.0346 |
Echinococcus granulosus | muscleblind protein | 0.0146 | 1 | 1 |
Echinococcus multilocularis | tar DNA binding protein | 0.0126 | 0.8468 | 0.8442 |
Echinococcus granulosus | cadherin EGF LAG seven pass G type receptor | 0.0031 | 0.1013 | 0.086 |
Loa Loa (eye worm) | RNA binding protein | 0.0126 | 0.8468 | 0.8442 |
Schistosoma mansoni | acetyl-CoA C-acetyltransferase | 0.0027 | 0.0689 | 0.0813 |
Brugia malayi | calcium-independent alpha-latrotoxin receptor 2, putative | 0.0031 | 0.1013 | 0.0109 |
Schistosoma mansoni | methyl-cpg binding protein mbd | 0.0021 | 0.0167 | 0.0197 |
Echinococcus granulosus | diuretic hormone 44 receptor GPRdih2 | 0.0031 | 0.1013 | 0.086 |
Loa Loa (eye worm) | TAR-binding protein | 0.0126 | 0.8468 | 0.8442 |
Brugia malayi | RNA binding protein | 0.0126 | 0.8468 | 0.8314 |
Schistosoma mansoni | hypothetical protein | 0.0068 | 0.3876 | 0.4577 |
Echinococcus multilocularis | bromodomain adjacent to zinc finger domain | 0.0043 | 0.1961 | 0.1825 |
Loa Loa (eye worm) | hypothetical protein | 0.0068 | 0.3876 | 0.3772 |
Loa Loa (eye worm) | MH2 domain-containing protein | 0.012 | 0.7988 | 0.7954 |
Schistosoma mansoni | histone-lysine n-methyltransferase setb1 | 0.0021 | 0.0167 | 0.0197 |
Echinococcus multilocularis | cadherin EGF LAG seven pass G type receptor | 0.0031 | 0.1013 | 0.086 |
Schistosoma mansoni | hypothetical protein | 0.0031 | 0.1013 | 0.1196 |
Loa Loa (eye worm) | hypothetical protein | 0.0049 | 0.2418 | 0.2289 |
Loa Loa (eye worm) | hypothetical protein | 0.0146 | 1 | 1 |
Schistosoma mansoni | hypothetical protein | 0.0031 | 0.1013 | 0.1196 |
Brugia malayi | MH2 domain containing protein | 0.012 | 0.7988 | 0.7785 |
Loa Loa (eye worm) | hypothetical protein | 0.0046 | 0.2193 | 0.206 |
Schistosoma mansoni | hypothetical protein | 0.0025 | 0.0507 | 0.0599 |
Trypanosoma brucei | ISWI complex protein | 0.0018 | 0 | 0.5 |
Loa Loa (eye worm) | latrophilin receptor protein 2 | 0.0031 | 0.1013 | 0.086 |
Loa Loa (eye worm) | bromodomain containing protein | 0.0021 | 0.0225 | 0.0059 |
Loa Loa (eye worm) | hypothetical protein | 0.0085 | 0.5268 | 0.5188 |
Echinococcus multilocularis | GPCR, family 2 | 0.0031 | 0.1013 | 0.086 |
Schistosoma mansoni | hypothetical protein | 0.0031 | 0.1013 | 0.1196 |
Echinococcus multilocularis | muscleblind protein 1 | 0.0146 | 1 | 1 |
Schistosoma mansoni | tar DNA-binding protein | 0.0126 | 0.8468 | 1 |
Loa Loa (eye worm) | hypothetical protein | 0.0052 | 0.2599 | 0.2474 |
Schistosoma mansoni | tar DNA-binding protein | 0.0126 | 0.8468 | 1 |
Echinococcus multilocularis | bromodomain adjacent to zinc finger domain | 0.0072 | 0.422 | 0.4122 |
Schistosoma mansoni | hypothetical protein | 0.0031 | 0.1013 | 0.1196 |
Schistosoma mansoni | histone-lysine n-methyltransferase setb1 | 0.0021 | 0.0167 | 0.0197 |
Echinococcus multilocularis | zinc finger protein | 0.0024 | 0.0407 | 0.0244 |
Activity type | Activity value | Assay description | Source | Reference |
---|---|---|---|---|
Potency (functional) | 0.7079 uM | PUBCHEM_BIOASSAY: qHTS Assay for Inhibitors of BAZ2B. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID504391] | ChEMBL. | No reference |
Potency (functional) | 0.8913 uM | PUBCHEM_BIOASSAY: qHTS for Inhibitors of binding or entry into cells for Lassa Virus. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID463114, AID540249] | ChEMBL. | No reference |
Potency (functional) | = 3.1623 um | PUBCHEM_BIOASSAY: qHTS Assay for Rab9 Promoter Activators. (Class of assay: confirmatory) | ChEMBL. | No reference |
Potency (functional) | 9.285 uM | PUBCHEM_BIOASSAY: Primary qHTS for delayed death inhibitors of the malarial parasite plastid, 96 hour incubation. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID488745, AID488752, AID488774, AID504848, AID504850] | ChEMBL. | No reference |
Potency (functional) | 10 uM | PubChem BioAssay. qHTS of GLP-1 Receptor Inverse Agonists (Inhibition Mode). (Class of assay: confirmatory) | ChEMBL. | No reference |
Potency (functional) | 89.1251 uM | PUBCHEM_BIOASSAY: qHTS for Inhibitors of Polymerase Iota. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID588623] | ChEMBL. | No reference |
Potency (functional) | 100 uM | PUBCHEM_BIOASSAY: qHTS for Inhibitors of Polymerase Eta. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID588636] | ChEMBL. | No reference |
Species name | Source | Reference | Is orphan |
---|---|---|---|
Homo sapiens | ChEMBL23 | ||
Plasmodium falciparum | ChEMBL23 |
Many chemical entities in TDR Targets come from high-throughput screenings with whole cells or tissue samples, and not all assayed compounds have been tested against a single a single target protein, probably because they get ruled out during screening process. Even if these compounds may have not been of interest in the original screening, they may come as interesting leads for other screening assays. Furthermore, we may be able to propose drug-target associations using chemical similarities and network patterns.